Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice

Cell Transplantation

Volumn 21, Issue 7, 2012, Pages 1419-1430

  Fakhfakh, Raouia ^a   Lee, Se Jin ^b   Tremblay, Jacques P ^a  

^a LAVAL UNIVERSITY   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activin receptor; Duchenne muscular dystrophy (DMD); Myoblast transplantation; Transforming growth factor and beta; (TGF and beta; ) superfamily

Indexed keywords

ACTIVIN RECEPTOR 2; ACTIVIN RECEPTOR 2B; DYSTROPHIN; LAMIN; MYOGENIN; MYOSTATIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FORCED SWIMMING TEST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOTOR PERFORMANCE; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; MUSCLE REGENERATION; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; UPREGULATION;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; BODY WEIGHT; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INFANT; LAMINS; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MYOBLASTS; MYOD PROTEIN; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

MUS;

EID: 84868519883     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X627480     Document Type: Article

References (38)

1. Akpan, I.; Goncalves, M. D.; Dhir, R.; Yin, X.; Pistilli, E. E.; Bogdanovich, S.; Khurana, T. S.; Ucran, J.; Lachey, J.; Ahima, R. S. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity. Int. J. Obes. 33(11):1265-1273; 2009.
2. Amthor, H.; Nicholas, G.; McKinnell, I.; Kemp, C. F.; Sharma, M.; Kambadur, R.; Patel, K. Follistatin complexes myostatin and antagonises myostatin-mediated inhibition of myogenesis. Dev. Biol. 270(1):19-30; 2004.
3. Attisano, L.; Wrana, J. L.; Cheifetz, S.; Massague, J. Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68(1):97-108; 1992.
4. Benabdallah, B. F.; Bouchentouf, M.; Rousseau, J.; Bigey, P.; Michaud, A.; Chapdelaine, P.; Scherman, D.; Tremblay, J. P. Inhibiting myostatin with follistatin improves the success of myoblast transplantation in dystrophic mice. Cell Transplant. 17(3):337-350; 2008.
5. Benabdallah, B. F.; Bouchentouf, M.; Tremblay, J. P. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal. Transplantation 79(12):1696-1702; 2005.
6. Bogdanovich, S.; Krag, T. O.; Barton, E. R.; Morris, L. D.; Whittemore, L. A.; Ahima, R. S.; Khurana, T. S. Functional improvement of dystrophic muscle by myos-tatin blockade. Nature 420(6914):418-421; 2002.
7. Bogdanovich, S.; Perkins, K. J.; Krag, T. O.; Whittemore, L. A.; Khurana, T. S. Myostatin propeptide-mediated amelioration of dystrophic pathophysiology. FASEB J. 19(6):543-549; 2005.
8. Bouchentouf, M.; Benabdallah, B. F.; Mills, P.; Tremblay, J. P. Exercise improves the success of myoblast transplantation in mdx mice. Neuromuscul. Disord. 16(8):518-529; 2006.
9. Dubowitz, V. Neuromuscular disorders in childhood. Old dogmas, new concepts. Arch. Dis. Child. 50(5):335-346; 1975.
10. Emery, A. E. Population frequencies of inherited neuromuscular diseases-a world survey. Neuromuscul. Disord. 1(1):19-29; 1991.
11. Fakhfakh, R.; Michaud, A.; Tremblay, J. P. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice. Mol. Ther. 19(1):204-210; 2011.
12. Fan, Y.; Maley, M.; Beilharz, M.; Grounds, M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 19(7):853-860; 1996.
13. Garg, R. R.; Bally-Cuif, L.; Lee, S. E.; Gong, Z.; Ni, X.; Hew, C. L.; Peng, C. Cloning of zebrafish activin type IIB receptor (ActRIIB) cDNA and mRNA expression of ActRIIB in embryos and adult tissues. Mol. Cell. Endocrinol. 153(1-2):169-181; 1999.
14. Guerette, B.; Skuk, D.; Celestin, F.; Huard, C.; Tardif, F.; Asselin, I.; Roy, B.; Goulet, M.; Roy, R.; Entman, M.; Tremblay, J. P. Prevention by anti-LFA-1 of acute myoblast death following transplantation. J. Immunol. 159(5):2522-2531; 1997.
15. Hill, J. J.; Davies, M. V.; Pearson, A. A.; Wang, J. H.; Hewick, R. M.; Wolfman, N. M.; Qiu, Y. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. J. Biol. Chem. 277(43):40735-40741; 2002.
16. Hill, J. J.; Qiu, Y.; Hewick, R. M.; Wolfman, N. M. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: A novel protein with protease inhibitor and follistatin domains. Mol. Endocrinol. 17(6):1144-1154; 2003.
17. Huard, J.; Acsadi, G.; Jani, A.; Massie, B.; Karpati, G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5(8):949-958; 1994.
18. Jennekens, F. G.; ten Kate, L. P.; de Visser, M.; Wintzen, A. R. Diagnostic criteria for Duchenne and Becker muscular dystrophy and myotonic dystrophy. Neuromuscul. Disord. 1(6):389-391; 1991.
19. Kaufman, R. J. Vectors used for expression in mammalian cells. Methods Enzymol. 185:487-511; 1990.
20. Kinoshita, I.; Roy, R.; Dugre, F. J.; Gravel, C.; Roy, B.; Goulet, M.; Asselin, I.; Tremblay, J. P. Myoblast transplantation in monkeys: Control of immune response by FK506. J. Neuropathol. Exp. Neurol. 55(6):687-697; 1996.
21. Lee, S. J.; McPherron, A. C. Myostatin and the control of skeletal muscle mass. Curr. Opin. Genet. Dev. 9(5): 604-607; 1999.
22. Lee, S. J.; McPherron, A. C. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA 98(16):9306-9311; 2001.
23. Lee, S. J.; Reed, L. A.; Davies, M. V.; Girgenrath, S.; Goad, M. E.; Tomkinson, K. N.; Wright, J. F.; Barker, C.; Ehrmantraut, G.; Holmstrom, J.; Trowell, B.; Gertz, B.; Jiang, M. S.; Sebald, S. M.; Matzuk, M.; Li, E.; Liang, L. F.; Quattlebaum, E.; Stotish, R. L.; Wolfman, N. M. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl. Acad. Sci. USA 102(50):18117-18122; 2005.
24. Li, Z. B.; Kollias, H. D.; Wagner, K. R. Myostatin directly regulates skeletal muscle fibrosis. J. Biol. Chem. 283(28): 19371-19378; 2008.
25. Morine, K. J.; Bish, L. T.; Selsby, J. T.; Gazzara, J. A.; Pendrak, K.; Sleeper, M. M.; Barton, E. R.; Lee, S. J.; Sweeney, H. L. Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of Duchenne muscular dystrophy. Muscle Nerve 42(5):722-730; 2010.
26. Morrison, B. M.; Lachey, J. L.; Warsing, L. C.; Ting, B. L.; Pullen, A. E.; Underwood, K. W.; Kumar, R.; Sako, D.; Grinberg, A.; Wong, V.; Colantuoni, E.; Seehra, J. S.; Wagner, K. R. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Exp. Neurol. 217(2):258-268; 2009.
27. Qiao, C.; Li, J.; Jiang, J.; Zhu, X.; Wang, B.; Xiao, X. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice. Hum. Gene Ther. 19(3):241-254; 2008.
28. Richard, P. L.; Gosselin, C.; Laliberte, T.; Paradis, M.; Goulet, M.; Tremblay, J. P.; Skuk, D. A first semimanual device for clinical intramuscular repetitive cell injections. Cell Transplant. 19(1):67-78; 2010.
29. Sako, D.; Grinberg, A. V.; Liu, J.; Davies, M. V.; Castonguay, R.; Maniatis, S.; Andreucci, A. J.; Pobre, E. G.; Tomkinson, K. N.; Monnell, T. E.; Ucran, J. A.; Martinez-Hackert, E.; Pearsall, R. S.; Underwood, K. W.; Seehra, J.; Kumar, R. Characterization of the ligand binding functionality of the extracellular domain of activin receptor type IIb. J. Biol. Chem. 285(27):21037-21048; 2010.
30. Skuk, D.; Goulet, M.; Roy, B.; Chapdelaine, P.; Bouchard, J. P.; Roy, R.; Dugre, F. J.; Sylvain, M.; Lachance, J. G.; Deschenes, L.; Senay, H.; Tremblay, J. P. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J. Neuropathol. Exp. Neurol. 65(4):371-386; 2006.
31. Skuk, D.; Goulet, M.; Tremblay, J. P. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant. 15(7): 659-663; 2006.
32. Skuk, D.; Roy, B.; Goulet, M.; Chapdelaine, P.; Bouchard, J. P.; Roy, R.; Dugre, F. J.; Lachance, J. G.; Deschenes, L.; Helene, S.; Sylvain, M.; Tremblay, J. P. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol. Ther. 9(3):475-482; 2004.
33. Skuk, D.; Tremblay, J. P. Progress in myoblast transplantation: a potential treatment of dystrophies. Microsc. Res. Tech. 48(3-4):213-222; 2000.
34. Souza, T. A.; Chen, X.; Guo, Y.; Sava, P.; Zhang, J.; Hill, J. J.; Yaworsky, P. J.; Qiu, Y. Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Mol. Endocrinol. 22(12):2689-2702; 2008.
35. Sunada, Y. Therapeutic strategies for muscular dystrophy by myostatin inhibition. Rinsho Shinkeigaku 46(11):942-944; 2006.
36. Thies, R. S.; Chen, T.; Davies, M. V.; Tomkinson, K. N.; Pearson, A. A.; Shakey, Q. A.; Wolfman, N. M. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18(4):251-259; 2001.
37. Wagner, K. R.; McPherron, A. C.; Winik, N.; Lee, S. J. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann. Neurol. 52(6):832-836; 2002.
38. Weintraub, H.; Dwarki, V. J.; Verma, I.; Davis, R.; Hollenberg, S.; Snider, L.; Lassar, A.; Tapscott, S. J. Muscle-specific transcriptional activation by MyoD. Genes Dev. 5(8):1377-1386; 1991.